Literature DB >> 8608231

A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5.

D Brugnoni1, P Airó, G Rossi, A Bettinardi, H U Simon, L Garza, C Tosoni, R Cattaneo, K Blaser, A Tucci.   

Abstract

Interleukin-5 (IL-5) is the major soluble factor able to mediate hypereosinophilia. We report a case of hypereosinophilic syndrome in which the presence of a population of CD3-CD4+ cells able to overproduce IL-5 was shown. The lack of CD3 and TCRAB membrane expression on otherwise phenotypically normal mature T lymphocytes together with the absence of detectable TCRBV mRNA and clonal rearrangement of TCRB gene suggested that the abnormal lymphocyte population was the expression of a peripheral T-cell lymphoma with an indolent clinical course. Peripheral blood lymphocytes enriched in this population were able to secrete high levels of IL-5 but not IL-4, and no IL-2 or interferon-gamma, when stimulated in vitro with phytohemagglutinin and phorbol myristate acetate. The serum contained eosinophil survival factors whose activity was partially neutralized by a specific antihuman IL-5 antibody. This observation further emphasized the relationship between hypereosinophilic syndrome. IL-5, and T-cell lymphoproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608231

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.

Authors:  Yorick Sandberg; Ellen J van Gastel-Mol; Brenda Verhaaf; King H Lam; Jacques J M van Dongen; Anton W Langerak
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

2.  Idiopathic hypereosinophilic syndrome with skull base involvement.

Authors:  M L Battineni; S L Galetta; J Oh; M Lango; J J Brooks; S J Schuster; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

3.  Eosinophilia: introduction.

Authors:  Amy D Klion
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

4.  Eosinophilia in a cat with acute leukemia.

Authors:  Cornelia Gilroy; María Forzán; Anne Drew; William Vernau
Journal:  Can Vet J       Date:  2011-09       Impact factor: 1.008

5.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

6.  Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma.

Authors:  Vikram K Mahajan; Ravinder Singh; Karaninder S Mehta; Pushpinder S Chauhan; Saurabh Sharma; Mrinal Gupta; Ritu Rawat
Journal:  J Dermatol Case Rep       Date:  2014-12-31

7.  CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.

Authors:  Guillaume Lefèvre; Marie-Christine Copin; Christophe Roumier; Hélène Aubert; Martine Avenel-Audran; Nathalie Grardel; Stéphanie Poulain; Delphine Staumont-Sallé; Julien Seneschal; Gilles Salles; Kamel Ghomari; Louis Terriou; Christian Leclech; Chafika Morati-Hafsaoui; Franck Morschhauser; Olivier Lambotte; Félix Ackerman; Jacques Trauet; Sandrine Geffroy; Florent Dumezy; Monique Capron; Catherine Roche-Lestienne; Alain Taieb; Pierre-Yves Hatron; Sylvain Dubucquoi; Eric Hachulla; Lionel Prin; Myriam Labalette; David Launay; Claude Preudhomme; Jean-Emmanuel Kahn
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

Review 8.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

9.  More than 13 years of hypereosinophila associated with clonal CD3-CD4+ lymphocytosis of TH2/TH0 type.

Authors:  Koichi Sugimoto; Kenji Tamayose; Makoto Sasaki; Takashi Danbara; Yosuke Aikawa; Hideoki Ogawa; Naotake Sato; Eiji Tashiro; Kazuo Oshimi
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

10.  Chronic eosinophilic leukemia with the FIP1L1-PDGFRalpha fusion gene in a patient with a history of combination chemotherapy.

Authors:  Yasuhiro Tanaka; Masayuki Kurata; Katsuhiro Togami; Haruyuki Fujita; Naoko Watanabe; Akiko Matsushita; Akinori Maeda; Kenichi Nagai; Akiko Sada; Toshimitsu Matsui; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.